Patents by Inventor Lindsay Calderon

Lindsay Calderon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LHRH-platinum conjugates for treating reproductive cancers
    Patent number: 11197888
    Abstract: The conjugation of luteinizing hormone-releasing hormone (LHRH) with activated cisplatin using a malonate linker gives rise to a new Platinum-LHRH conjugate that effectively targets tumor cells that express the LHRH receptor. The Pt-LHRH conjugate may be used in a method for killing or inhibiting the growth of a tumor cell, especially in late state, highly invasive and aggressive stage IV tumors and in reoccurring tumors.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: December 14, 2021
    Assignee: Eastern Kentucky University
    Inventors: Margaret Ndinguri, Lindsay Calderon
  • LHRH-Platinum Conjugates for Treating Reproductive Cancers
    Publication number: 20190111077
    Abstract: The conjugation of luteinizing hormone-releasing hormone (LHRH) with activated cisplatin using a malonate linker gives rise to a new Platinum-LHRH conjugate that effectively targets tumor cells that express the LHRH receptor. The Pt-LHRH conjugate may be used in a method for killing or inhibiting the growth of a tumor cell, especially in late state, highly invasive and aggressive stage IV tumors and in reoccurring tumors.
    Type: Application
    Filed: October 12, 2018
    Publication date: April 18, 2019
    Applicant: Eastern Kentucky University
    Inventors: Margaret Ndinguri, Lindsay Calderon
  • LHRH-platinum conjugates for treating reproductive cancers
    Patent number: 10130717
    Abstract: The conjugation of luteinizing hormone-releasing hormone (LHRH) with activated cisplatin using a malonate linker gives rise to a new Platinum-LHRH conjugate that effectively targets tumor cells that express the LHRH receptor. The Pt-LHRH conjugate may be used in a method for killing or inhibiting the growth of a tumor cell, especially in late state, highly invasive and aggressive stage IV tumors and in reoccurring tumors.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: November 20, 2018
    Assignee: Eastern Kentucky University
    Inventors: Margaret Ndinguri, Lindsay Calderon
  • LHRH-Platinum Conjugates For Treating Reproductive Cancers
    Publication number: 20170157263
    Abstract: The conjugation of luteinizing hormone-releasing hormone (LHRH) with activated cisplatin using a malonate linker gives rise to a new Platinum-LHRH conjugate that effectively targets tumor cells that express the LHRH receptor. The Pt-LHRH conjugate may be used in a method for killing or inhibiting the growth of a tumor cell, especially in late state, highly invasive and aggressive stage IV tumors and in reoccurring tumors.
    Type: Application
    Filed: December 2, 2016
    Publication date: June 8, 2017
    Applicant: Eastern Kentucky University
    Inventors: Margaret Ndinguri, Lindsay Calderon